{
    "title": "Ozone vs Ebola",
    "inventor_name": "Robert Rowen, MD",
    "publication_year": 2016,
    "device_name": "Rowen-Robins Ozone Therapy Method (intravenous, rectal, and ozonized water administration)",
    "goal": "To treat and cure Ebola Virus Disease (EVD) using ozone therapy",
    "problem_addressed": "High mortality of Ebola virus infection and lack of effective approved treatments",
    "concept_summary": "The authors describe a protocol that delivers a mixture of oxygen/ozone gas intravenously (direct intravenous gas, DIV), rectally, and as ozonized water, supplemented with vitamin C and glutathione-supporting compounds. They claim that ozone's strong oxidizing power rapidly inactivates the Ebola virus by oxidizing essential sulfhydryl groups on viral glycoproteins, while also modulating the host immune response. In a case series of four Ebola-positive patients, symptoms resolved within 2-4 days and full recovery was achieved without complications.",
    "detailed_description": "The treatment protocol (Rowen-Robins Method) uses an ozone generator to produce an O_2/O_3 mixture (~=98 % O_2, 2 % O_3) at concentrations up to 55 ug/cc for intravenous infusion (20-40 cc per session). Rectal administration employs 36 ug/cc ozone (150-350 cc). Ozonized water is prepared by bubbling ozone at ~70 ug/cc into water for 15 min (300-500 cc) and taken orally. Patients also receive oral vitamin C (4-8 g/day) and a glutathione-recycling supplement (ThiodoxA(R)). The authors report immediate clinical improvement in four patients (three laboratory-confirmed, one high-risk exposure) and no disease development in a prophylactically treated high-risk individual.",
    "category": "Medical & Dental Technologies",
    "principles": [
        "Oxidation of viral sulfhydryl groups to disulfides",
        "Redox-mediated viral inactivation",
        "Immune modulation via antioxidant enzyme induction",
        "Improved blood rheology and oxygen delivery"
    ],
    "scientific_domains": [
        "Virology",
        "Immunology",
        "Medical Chemistry",
        "Clinical Medicine"
    ],
    "mechanisms_of_action": [
        "Intravenous ozone gas oxidizes viral envelope proteins",
        "Rectal ozone delivers systemic oxidative stress",
        "Ozonized water provides oral oxidative agents",
        "Vitamin C and glutathione support antioxidant recycling"
    ],
    "materials": [
        "Ozone gas (O_3)",
        "Oxygen (O_2)",
        "Water",
        "Vitamin C",
        "Glutathione-supporting supplement (ThiodoxA(R))",
        "Buffered Vitamin C(R)"
    ],
    "energy_sources": [
        "Electricity (for ozone generator)"
    ],
    "inputs": [
        "Ozone/oxygen gas mixture",
        "Rectal ozone gas",
        "Ozonized water",
        "Vitamin C tablets",
        "ThiodoxA(R) supplement"
    ],
    "outputs": [
        "Rapid symptom remission",
        "Complete clinical recovery",
        "Viral inactivation"
    ],
    "claimed_performance": "Four of four Ebola-positive patients recovered within 2-4 days after initiation of ozone therapy; a fifth high-risk individual remained asymptomatic.",
    "experimental_evidence": "Case series of four patients reported in the African Journal of Infectious Diseases (2016) with documented symptom resolution and recovery.",
    "replication_status": "No independent replication reported; results confined to the authors' case series.",
    "keywords": [
        "Ozone therapy",
        "Ebola virus disease",
        "IV ozone",
        "Redox inactivation",
        "Viral infection",
        "Clinical case series"
    ],
    "related_technologies": [
        "Hyperbaric oxygen therapy",
        "Antiviral oxidants",
        "Immunomodulatory supplements"
    ],
    "controversy_level": "high",
    "confidence_score": 0.6,
    "practicability_score": 0.7,
    "fringe_score": 0.5,
    "evidence_strength": 0.4,
    "risk_score": 0.3,
    "trl_estimate": 4,
    "source_urls": [
        "http://dx.doi.org/10.4314/ajid.v10i1.10",
        "http://www.docrowen.com/ozone-cures-eboa.html",
        "https://www.youtube.com/watch?v=56ZKXKaxdQo"
    ],
    "organizations": [
        "Allergy Research Group",
        "African Journal of Infectious Diseases"
    ],
    "applications": [
        "Treatment of Ebola virus disease",
        "Potential therapy for other viral infections"
    ],
    "limitations": [
        "Very small sample size (n = 4)",
        "No control or placebo group",
        "Lack of quantitative virological data",
        "Potential for ozone-related toxicity if mis-administered"
    ],
    "open_questions": [
        "What is the optimal dosing regimen for intravenous ozone in viral infections?",
        "Can the antiviral effect be demonstrated in vitro with live Ebola virus?",
        "Are there long-term safety concerns with repeated ozone administration?"
    ],
    "red_flags": [
        "Claims of cure based on anecdotal case series",
        "Absence of peer-reviewed randomized controlled trials",
        "Potential conflict of interest (authors are developers of the method)"
    ],
    "evidence_quotes": [
        "Four symptomatic patients... remitted symptoms within 2-4 days and fully recovered.",
        "The single case of non-symptomatic high-risk exposure treated preventively did not develop symptoms.",
        "Ozone kills bacteria in easily reachable concentrations nearly instantly... and some 100 times faster than chlorine containing disinfectants.",
        "Ozone inactivates many viruses including polio, Norwalk, coliphage MS2, hepatitis A and others."
    ]
}